BBB National Programs Decision Summaries
BBB National Programs provides summaries of all case decisions from the National Advertising Division (NAD), National Advertising Review Board (NARB), Children’s Advertising Review Unit (CARU), Direct Selling Self-Regulatory Council (DSSRC), and Digital Advertising Accountability Program (DAAP). Subscribe to receive a weekly wrap-up of published case decisions in your inbox.
- All
-
11/13/2012 - NAD Recommends Capital One Discontinue Certain Claims for Spark Cards; Company to Appeals NAD’s Findings
The National Advertising Division has recommended that Capital One Bank (USA), N.A., discontinue print, broadcast, and website advertising challenged by Chase Bank USA, N.A. Capital One said it will appeal NAD’s decision to the National Advertising Review Board. -
11/13/2012 - NAD Finds Sumo Logic Took Necessary Action in Discontinuing Comparative Claims Against Splunk
The National Advertising Division has determined that Sumo Logic took necessary action in discontinuing advertising claims challenged by Splunk, Inc., a maker of software for log management and analytic systems. -
11/11/2012 - NAD Recommends Verizon Modify, Discontinue Certain Comparative Superiority Claims for FiOS
The National Advertising Division has recommended that Verizon modify certain broadcast advertising to avoid conveying the falsely disparaging, unsupported message that Internet service provided by cable companies is significantly slower than Verizon’s fiber-optic FiOS service. -
10/25/2012 - NAD Reviews Claims for V8 Juices Following Ocean Spray Challenge
The National Advertising Division has determined that Campbell Soup Company can support advertising claims for original V8 Vegetable Juice, challenged before NAD by Ocean Spray Cranberries, Inc. -
10/11/2012 - NAD Finds Generac Violated NAD Procedures in Communication to Customers
The National Advertising Division has determined that Generac, the maker of home generators, violated the procedures that govern the advertising industry’s system of self-regulation. Generac promoted the outcome of a case heard by NAD directly to Generac customers and, in the process, mischaracterized NAD’s findings. -
10/09/2012 - NAD Finds Kohler Violated NAD Procedures in Communication to Customers
The National Advertising Division has determined that Kohler Co. violated the procedures that govern the advertising industry’s system of self-regulation by promoting the outcome of a case directly to Kohler customers. -
9/27/2012 - NAD Finds McNabb Can Support Modified Claims for ‘Natural’ Sunscreen
The National Advertising Division has determined that McNabb Nutraceuticals, LLC, can support, with appropriate disclosures, claims that its Sunology Sunblock is a natural or chemical-free sunscreen. NAD recommended, however, that the company discontinue claims that the product moisturizes, as well. -
9/20/2012 - NAD Recommends Church & Dwight Discontinue ‘First and Only’ Claim for ‘First Response’ Ovulation Test Product
The National Advertising Division has recommended that Church & Dwight discontinue its claim that the company’s First Response digital ovulation test is the “First and Only Test to Predict Ovulation Based on Your Unique LH Hormone Level.” -
9/11/2012 - NAD Recommends Origins Modify, Discontinue Certain Claims for Two ‘Plantscription’ Products
The National Advertising Division has recommended that Origins Natural Resources, Inc., modify or discontinue certain advertising claims for the company’s anti-aging products “Plantscription Serum” and “Plantscription Eye Treatment,” including claims that imply the products produce a benefit similar to prescription anti-aging treatments. -
9/01/2012 - NAD Recommends Pharmapro Discontinue Wide Range of Claims for ‘Sterodol,’ Promoted as ‘Legal’ Alternative to Steroids
The National Advertising Division has recommended that Pharmapro, Inc., discontinue a wide range of advertising claims for the dietary supplement Sterodrol , including claims that the product is the “most powerful size and strength gaining compound available,” and a legal alternative to anabolic steroids.